Test Price
2,800 AED✅ Home Collection Available
KRT71 Gene Hypotrichosis Type 13 Genetic Test in Dubai | 2800 AED | DHA Licensed Facility
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO-certified processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM).
- Post-Test Guidance: Telephonic clinical interpretation session with a DHA-licensed genetic counsellor.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The KRT71 gene hypotrichosis type 13 genetic test identifies pathogenic variants in the KRT71 gene causing hereditary hair loss disorder. Using targeted Next-Generation Sequencing (NGS), the assay covers the entire coding region and splice sites with high analytical sensitivity and specificity, enabling precise diagnosis and informed genetic counselling. This test is indicated for individuals with early-onset, progressive hair thinning or congenital hypotrichosis.
| Feature | Our Test (Centre of Excellence) | Closest Alternative |
|---|---|---|
| Methodology | Targeted Next-Generation Sequencing (NGS) | Sanger sequencing (limited to single exon screening) |
| Turnaround Time | 21–28 days (express reporting available upon request) | 6–8 weeks |
| Clinical Support | DHA-licensed geneticist pre- & post-test counselling included | Report only; interpretation not guaranteed |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I emphasize the importance of accurate genetic diagnosis for hereditary hair loss disorders. The NGS panel for KRT71 provides comprehensive coverage of the gene, but results must be interpreted alongside clinical presentation, family history, and a three-generation pedigree. I strongly recommend completing a formal genetic counselling session before and after testing to fully understand inheritance patterns, recurrence risks, and management options for the patient and family members."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Warning:
Do not discontinue any prescribed medication without consulting your doctor. This genetic test is not a substitute for ongoing dermatologic or genetic management and does not alter existing treatment plans.
Exclusion Criteria & Emergency Red Flags
- Active chemotherapy or radiotherapy within the last 4 weeks (may affect DNA integrity and test accuracy).
- Severe thrombocytopenia or bleeding disorder contraindicating phlebotomy.
- If you develop acute skin infection, fever >38.5°C, or uncontrolled bleeding at the collection site, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the exact accuracy of this test for detecting hypotrichosis type 13?
The NGS assay achieves over 99.9% analytical sensitivity and specificity for the KRT71 coding region, validated per ISO 9001:2015 standards. However, clinical sensitivity depends on the completeness of the gene coverage and the presence of non-coding or large deletions not detected by this panel.
2. How is sample collection performed at home, and is it suitable for children?
Our paediatric-trained phlebotomists use a virtually painless finger-prick or FTA card method, with hospital-grade safety protocols. The entire process takes under 10 minutes and is suitable for children with parental consent. Cold-chain transport ensures sample integrity.
3. Does UAE law protect my genetic data privacy?
Yes, your data is handled under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genomic information is never shared without explicit, DHA-compliant consent, and all test results are encrypted and stored securely.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — ensures your genetic data is processed lawfully, fairly, and with explicit consent.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — mandates secure electronic health information systems and data breach notification.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — governs clinical safety and patient consent for diagnostic procedures including genetic testing.
- DHA Facility License No. 1143 — issued to DNA Labs UAE, operating from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | KRT71 Gene Hypotrichosis Type 13 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 21–28 days (express reporting available) |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) or FTA card |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q84.0 (Congenital alopecia), L65.0 (Hypotrichosis) |
| LOINC Code | 21636-6 (Genetic analysis result) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians